Sulfonated tryptanthrin anolyte increases performance in pH neutral aqueous redox flow batteries

Climate changes have led to the emergence of environmental questions in the top group of concerns for mankind. Clean and sustainable energy sources are becoming more attractive as power generation moves away from combustion-based technology.

Published in Chemistry

Sulfonated tryptanthrin anolyte increases performance in pH neutral aqueous redox flow batteries
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

The demand for solar energy is in a counter-cycle with the supply of sunlight. So, how can we directly convert solar energy into storable energy? Energy storage is an emerging sector in constant development that is reshaping the renewable energy market. However, the development of environmentally friendly ways of store clean energy is urgently needed.

Redox flow batteries (RFBs) are currently being considered to be one of the most promising technologies for storage of electrical energy. Commercial RFBs are vanadium-based which show problems in solar energy capture and storage in form of chemical energy. Thus, the development of organic redox flow batteries, in particular those that work in aqueous media (AORFBs)  based on trypthatrin derivatives, constitutes not only a sustainable alternative for vanadium based technology, but also to the current organic RFB which is still strongly focused on anthraquinone derivatives.

We report the synthesis of a new electrolyte material, a water soluble form of tryptanthrin (TRYP), to be used as the anolyte in two types of RFBs: aqueous organometallic and all-organic. A lab prototype was used to test the RFB, showing promising values of efficiencies and storage capacities. Moreover,  this RFB operates at neutral pH values, thus avoiding extreme conditions of strongly acidic and alkaline media, which are not only corrosive (decreasing the lifetime of the battery) but also more environmentally friendly. This is relevant in terms of sustainability.

This new family of water soluble molecules (based on TRYP) paves the way for the use of this core structure for the successful development of new active materials for aqueous RFBs.

In our photochemistry group we investigate new molecular systems for capture and storage of energy. You can have a glance of our group and what we are presently doing at Photochemistry @ UC.

If you are interested to find more information our new active material and this attractive energy storage technology (RFBs), check out our paper (with Daniela Pinheiro and Marta Pineiro)  here  DOI: 10.1038/s42004-021-00523-0.

References

[1] Pinheiro D, Pineiro M, de Melo JSS (2021) Sulfonated tryptanthrin anolyte increases performance in pH neutral aqueous redox flow batteries. Communications Chemistry 4 (1):89. doi:10.1038/s42004-021-00523-0

[2] Lima ARF, Pereira RC, Azevedo J, Mendes A, Sérgio Seixas de Melo J (2021) On the path to aqueous organic redox flow batteries: Alizarin red S alkaline negolyte. Performance evaluation and photochemical studies. Journal of Molecular Liquids 336:116364. doi:https://doi.org/10.1016/j.molliq.2021.116364

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Chemistry
Physical Sciences > Chemistry

Related Collections

With collections, you can get published faster and increase your visibility.

Crystal polymorphism

This Collection aims to showcase research on small molecule and crystalline framework polymorphism, with a focus on applications in pharmaceutical and materials sciences, as well as state-of-the-art techniques for the prediction, analysis, and characterisation of polymorphs.

Publishing Model: Open Access

Deadline: Jul 31, 2025

Computational methodology for drug discovery

This Collection aims to collate the latest advances in computational method development for drug discovery and medicinal chemistry, as well as their application in preclinical studies.

Publishing Model: Open Access

Deadline: Aug 31, 2025